Mylan Can't Decertify EpiPen Antitrust Action Ahead Of Trial
By Lauren Berg · December 15, 2021, 9:43 PM EST
A Kansas federal judge on Wednesday largely denied Mylan's bid ahead of trial next month to decertify antitrust class action claims accusing the pharmaceutical company of causing a delay in the...
To view the full article, register now.